var data={"title":"Interactive diabetes case 9: Management of type 1 diabetes in a patient on glucocorticoid therapy - B3","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Interactive diabetes case 9: Management of type 1 diabetes in a patient on glucocorticoid therapy - B3</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/interactive-diabetes-case-9-management-of-type-1-diabetes-in-a-patient-on-glucocorticoid-therapy-b3/contributors\" class=\"contributor contributor_credentials\">Lloyd Axelrod, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/interactive-diabetes-case-9-management-of-type-1-diabetes-in-a-patient-on-glucocorticoid-therapy-b3/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 22, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">ANSWER</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Incorrect.</p><p>First of all, this is not an optimal time to change the types of insulin used by the patient. A conversion to a glargine and lispro regimen usually requires some adjustment of doses, even in a well-controlled diabetic patient. In the present case, this variable would then be added to the hyperglycemic effect produced by the use of <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a>. The patient was well controlled before the start of prednisone, so little is to be gained from conversion to glargine and lispro. </p><p><ul class=\"bulletCompact-block\"><li>Secondly, an intermediate-acting basal insulin (in particular, NPH insulin) given in the morning is probably the preferred basal insulin for a patient treated with a short-acting glucocorticoid such as <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a> once daily in the morning. The time course of action of NPH insulin roughly approximates the time course of the hyperglycemic effect of a short-acting glucocorticoid such as prednisone.</li></ul></p><p>Return to the previous choice to try again. (See <a href=\"topic.htm?path=interactive-diabetes-case-9-management-of-type-1-diabetes-in-a-patient-on-glucocorticoid-therapy-a2\" class=\"medical medical_answer\">&quot;Interactive diabetes case 9: Management of type 1 diabetes in a patient on glucocorticoid therapy - A2&quot;</a>.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 4164 Version 4.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H1\" id=\"outline-link-H1\">ANSWER</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=interactive-diabetes-case-9-management-of-type-1-diabetes-in-a-patient-on-glucocorticoid-therapy-a2\" class=\"medical medical_answer\">Interactive diabetes case 9: Management of type 1 diabetes in a patient on glucocorticoid therapy - A2</a></li></ul></div></div>","javascript":null}